Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015',

In this issue

Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 44 Article 3
Back to Table of Contents

Eurosurveillance, Volume 7, Issue 44, 31 October 2003

Citation style for this article: Chow Y. Consensus document on the epidemiology of SARS. Euro Surveill. 2003;7(44):pii=2318. Available online:

Consensus document on the epidemiology of SARS

Yimmy Chow, Health Protection Agency Communicable Disease Surveillance Centre, London, England, and the editorial team (, Eurosurveillance editorial office.

The World Health Organization (WHO) has issued a consensus document on severe acute respiratory syndrome (SARS) (1). The 35 page report summarises the international research on the epidemiology of the SARS outbreak, representing the views of experts in public health, epidemiology, and clinical virology. It uses experiences from the main outbreak sites including published and unpublished documents and information from the weekly teleconferences of the WHO ad hoc working group on the epidemiology of SARS.

Some of the main conclusions from the report include:

There is no evidence that SARS is an airborne disease
Healthcare workers were at special risk
The risk of transmission is greatest at around day ten of illness
There is no evidence that patients transmit infection ten days after fever has resolved
Children are rarely affected by SARS

The report was released at the start of four consecutive SARS meetings hosted by WHO in Geneva, which have concentrated on the priorities for scientific research, laboratory issues, clinical treatment protocols, and prospects for vaccine development.

At the first of these meetings, the WHO SARS Scientific Research Advisory Committee met to identify the most urgent areas of research into SARS, and make preparations for the possible recurrence of the disease (2). Issues discussed included:

The global SARS alert system
Preparedness in resource-poor settings
Possible evolution of the SARS coronavirus
Amplification in hospitals: the role of infection control
Laboratory biosafety
Control interventions

  1. WHO Department of Communicable Disease, Surveillance and Response. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). WHO/CDS/CSR/GAR/2003.11. Geneva: World Health Organization; 17 October 2003. ( [accessed 31 October 2003]
  2. WHO CSR Situation updates-SARS. WHO SARS Scientific Research Advisory Committee concludes its first meeting. 22 October 2003. ( [accessed 31 October 2003]

back to top

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.